Trial Profile
A pharmacokinetic study to assess the comparative bioavailability of 17-B-estradiol from Metered-Dose Transdermal Sprays (MDTS) and Estraderm 50 patches as hormone replacement therapy in postmenopausal women.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Jun 2016
Price :
$35
*
At a glance
- Drugs Estradiol (Primary)
- Indications Menopausal syndrome
- Focus Pharmacokinetics
- Sponsors Acrux DDS; Fempharm
- 10 Feb 2009 New trial record